New Developments in LAA Closure Safety, Efficacy and Procedural Approaches

Activity Description
The world-renowned faculty evaluate the latest developments in LAA Closure safety, efficacy, and procedural approaches, including updates to procedure flow, post implant drug regimen, and expanded opportunities to engage previous screen fails and abandoned cases.

Agenda

On-Demand Access
Click on session titles within the agenda to view that segment of the activity.

Agenda
		LAA Occlusion: Implant Tips and Tricks Walid Saliba, MD
		Changes to Left Atrial Appendage Closure Procedure Flow Shephal Doshi, MD
		Latest Post-Implant Drug Regimen Luigi Di Biase, MD, PhD, FHRS
		Opportunities for Engaging Prior Screen Fails/Abandoned Cases Christopher Ellis, MD, FACC
		Panel Discussion with Q&A Session Moderator: Vivek Reddy, MD *Panel:* Shephal Doshi, MD, Walid Saliba, MD, Luigi Di Biase, MD, PhD, FHRS, Christopher Ellis, MD, FACC

Educational grant support provided by:
Boston Scientific

Joint Providership:
MediaSphere Medical, LLC and Ciné-Med

Faculty

Program Director
	Vivek Reddy, MD Director of Cardiac Arrhythmia Services The Mount Sinai Hospital The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Cardiac Electrophysiology at Icahn School of Medicine at Mount Sinai New York, NY
Faculty
	Luigi Di Biase, MD, PhD, FHRS Section Head of Electrophysiology, Director of Arrhythmia Services, and Professor of Medicine Albert Einstein College of Medicine at Montefiore Hospital Bronx, NY
	Shephal Doshi, MD Director, Cardiac Electrophysiology Providence Saint Johns Health Center Pacific Heart Institute Santa Monica, CA
	Christopher Ellis, MD, FACC Associate Professor of Cardiac Electrophysiology Director, Cardiac Electrophysiology Laboratory Director, LAA Closure Program Vanderbilt Heart Nashville, TN
	Walid Saliba, MD Medical Director, EP lab Director of the Atrial Fibrillation Center Cleveland Clinic Cleveland, OH